Syncom Formulations has scheduled its 38th Annual General Meeting (AGM) for September 30, 2026. The meeting will commence at 2:00 pm via Video Conferencing or Other Audio Visual Means. Key agenda items include the appointment of Mr. Rahul Vijay Bankda as Managing Director and Mrs. Rinki Ankit Bankda as Whole-Time Director.

The company submitted the notice alongside its 38th Annual Report for FY26. The filing includes the balance sheet, profit and loss statement, cash flow statement, and statement of changes in equity. Syncom achieved total revenue of ₹51,753.91 crore and Profit Before Tax of ₹10,052.51 crore for the financial year ended March 31, 2026.

Board Appointments

Shareholders will vote on several key managerial appointments:

• Managing Director: Mr. Rahul Vijay Bankda will be appointed as Managing Director for three years, effective August 12, 2026. His proposed remuneration is up to ₹1.2 crore per annum with a 10% annual increment.
• Whole-Time Director: Mrs. Rinki Ankit Bankda will be appointed as Whole-Time Director for three years, effective August 12, 2026. Her proposed remuneration is up to ₹60 lakh per annum with a 10% annual increment.
• CFO Remuneration: The remuneration of Chief Financial Officer Mr. Ankur Vijay Bankda will be increased from ₹2.25 lakh per month to ₹3.50 lakh per month, effective October 1, 2026.
• Independent Director: Mrs. Ruchi Jindal will be re-appointed as an Independent Director for a second term of five years, effective June 28, 2027.

Dividend Declaration

The Board proposes a final dividend of 10%, i.e., ₹0.10 per equity share of face value ₹1 each, for FY26. The record date for determining eligible shareholders is September 23, 2026. Payment is scheduled before October 30, 2026.

Regulatory Compliance

The submission adheres to Regulation 34(1) of the SEBI (LODR) Regulations, 2015. Documents were filed on September 7, 2026, with both the Bombay Stock Exchange and the National Stock Exchange of India. The annual report also contains the Board’s Report, Corporate Governance Report, Business Responsibility and Sustainability Report (BRSR), and the Auditors’ Report.

Vaishali Agrawal, Company Secretary and Compliance Officer, signed the submission digitally.

Syncom Formulations has filed its Business Responsibility and Sustainability Report (BRSR) for the financial year ended March 31, 2026. The submission, made pursuant to Regulation 34(2)(f) of the SEBI (LODR) Regulations, 2015, outlines the company’s environmental, social, and governance disclosures.

The report confirms that pharmaceutical manufacturing accounts for 92.62% of the entity’s turnover. Exports remain a dominant revenue driver, contributing 82.94% of total standalone sales turnover of ₹48,657.28 lakh. Domestic sales accounted for the remaining 17.05%.

Workforce and Governance

As of March 31, 2026, the company employed a total of 2,429 employees and 361 workers. Permanent employees constituted the majority of the staff, with 717 individuals in that category. The gender distribution shows 94% male and 6% female representation among employees.

Turnover rates for permanent employees stood at 28% in FY26, an increase from 25% in FY25 and significantly lower than the 39% recorded in FY24. For permanent workers, the turnover rate remained stable at 9% compared to 8% in the previous year.

Environmental Disclosures

Total energy consumption rose to 65,68,586.4 units in FY26 from 53,37,685 units in FY25. Renewable energy sources contributed 11,76,680.4 units, while non-renewable sources accounted for 53,91,906 units. Water withdrawal remained largely consistent at 48,114 kilolitres, down slightly from 48,633 kilolitres in the prior year.

What the Numbers Show

The data reveals a distinct divergence in employee retention stability between fiscal years. While the overall turnover rate for permanent employees decreased from 39% in FY24 to 25% in FY25, it rebounded to 28% in FY26. This volatility contrasts with the steady 9% turnover rate for permanent workers over the same period, suggesting differing retention dynamics between salaried staff and industrial labor.

The company reported no fatalities or high-consequence work-related injuries in FY26. Air emissions metrics showed reductions in NOx (58.94 mg/m³ vs 65.42 mg/m³) and SOx (39.86 mg/m³ vs 44.2 mg/m³) compared to the previous year.